Healthcare Facilities company Yatharth Hospital & Trauma Care Services announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Operating Revenue at Rs 2,318 million, up 30% YoY Bed occupancy at 61%, compared to 57% in Q4 FY24 ARPOB at Rs 31,441, up 7% YoY Noida Extension registers highest ARPOB at Rs 38.8k (+11% YoY), followed by Greater Noida at Rs 35k (+16% YoY) EBITDA at Rs 570 million, up 23% YoY; EBITDA margin at 24.6% PBT at Rs 485 million, up 10% YoY and 21% QoQ PAT at Rs 387 million, up 1% YoY and 27% QoQ, due to lower taxes in the base year Received possession of two upcoming hospitals – a 300+ bed facility in Delhi and a ~400 bed facility in Faridabad – both of which are expected to become operational in Q1 FY26 FY25 Financial Highlights: Operating Revenue at Rs 8,805 million, up 31% YoY Bed occupancy at 61%, compared to 54% in FY24 Noida Extension and Jhansi-Orchha occupancy improves significantly to ~60% & 50% respectively in FY25, compared to 44% & 23% in FY24 ARPOB at Rs 30,829, up 8% YoY Noida Extension ARPOB at Rs 38k, marking a 12% increase over FY24, while Greater Noida recorded an ARPOB of Rs 34.6k, reflecting a robust 20% YoY growth. These improvements reflect the effectiveness of the strategic focus on super-specialty services. Faridabad achieves an ARPOB of Rs 31k EBITDA at Rs 2,202 million, up 22% YoY; EBITDA margin at 25.0%, compared to 26.8% in the previous year, due to initial ramp-up costs associated with the newly operationalized Greater Faridabad facility Depreciation increased to Rs 572 million, reflecting the expansion of our bed capacity and investment in advanced medical equipment across key hospitals PAT at Rs 1,306 million, up 14% YoY; PAT margin at 14.8% Net Cash position as on Mar-25 stood at Rs 5,032 million Commenting on the performance, Yatharth Tyagi, Whole Time Director, Yatharth Hospitals said: “We are pleased to report another quarter and year of robust growth at Yatharth Hospitals. Notably, our Operating Cash Flows were healthy at Rs 1,496 million in FY2025, with a cash conversion ratio of 68%, reflecting healthy profit to cash flows conversion. During the quarter, we received possession of our two newly acquired hospitals in New Delhi and Faridabad, adding approximately 300 and 400 beds, respectively, which are getting operationalise in Q1FY26. Looking ahead, we remain confident in our ability to sustain our growth trajectory, supported by significant investments in bed capacity expansion and advanced medical infrastructure.” Result PDF